Chouhan holds post-Budget discussion with coconut farmers in Chennai (See 'Corp Brief') IBC - Creditor cannot be forced to elect its remedy or apportion its claim between principal debtor and guarantor: SC (See 'Legal Desk') IBC - Judicial review by NCLT & NCLAT does not extend commercial wisdom of Committee of Creditors in evaluating and approving resolution plan: SC (See 'Legal Desk') A&C - Pre-award and post-award interest operate in distinct fields and contractual bar applicable to former cannot, by implication, be extended to latter: SC (See 'Legal Desk') MoS interacts with beneficiaries of desalination plant in Kavaratti (See 'Corp Brief') A&C - Court will not grant specific performance of contractual obligation that is contingent upon discretionary approval of third-party government authority: HC (See 'Legal Desk') A&C - Contractual clause that expressly and widely bars payment of interest on ‘any moneys due to contractor' prohibits arbitral tribunal from awarding pre-reference and pendente lite interest on all claims: HC (See 'Legal Desk') CCI approves acquisition of certain shareholding in Balaji Wafers by General Atlantic Singapore (See 'Corp Brief') CCI approves combination of Bagmane Prime Office REIT of Bagmane Developers and others (See 'Corp Brief') CCI okays acquisition of additional equity in Generali Central Insurance by Central Bank (See 'Corp Brief') India and Finland renew MoU on Environmental Cooperation (See 'Corp Brief') IPR - Proof of right refers to documents showing that applicant legally owns 'right to apply for patent', which can be established through assignment or employment agreement with inventor: HC (See 'Legal Desk') Crude and Petroleum procurement: 24×7 Control Room Monitoring Supply Position (See 'Corp Brief') On World Wildlife Day 2026, PM reaffirms Commitment to Wildlife Conservation (See 'Corp Brief') IBC - valuers must ensure a reasoned valuation report to guide stakeholders in economic decision-making during insolvency, including consideration of intangible assets where relevant: IBBI (See 'Legal Desk') GPS transforming fishing community lives in Car Nicobar (See 'Corp Brief') Competition Act - disputes concerning alteration of copyrighted content & associated rights, need not be entertained where no prima facie case of anti-competitive agreement or abuse of dominant position, is made out: CCI (See 'Legal Desk') Ministry of Steel holds Interactive Session with Global Diplomats Ahead of 'Bharat Steel 2026' (See 'Corp Brief') Khadse announces unique nationwide ASMITA League to mark International Women's Day (See 'Corp Brief') IPR – Anti-dissection rule, which requires trademarks to be compared as whole, does not apply where part of mark is proven to be dominant feature: HC (See 'Legal Desk') India Summit 2026: Major AI Investment Commitments made (See 'Corp Brief') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

13,822 Jan Aushadhi Kendras established across country

Published: Oct 04, 2024

By TIOLCorplaws News Service

NEW DELHI, OCT 04, 2024: UNDER the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, as of September 30, 2024, a total of 13,822 Jan Aushadhi Kendras have been established across the country. Notably, in September 2024, these Kendras achieved record sales of Rs.200 Crores - the highest monthly sales in the history of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.

For comparison, in September 2023, sales were Rs.141 Crores, highlighting a significant 42% growth on year to year basis. This remarkable increase reflects the programs success in providing affordable and accessible healthcare solutions to the masses. Overall up to September 2024, there has been 31.20% of total annual growth as sales target of Rs. 913.30 Cr. has already been achieved. Almost 10 lakh people daily purchase medicines from Jan Aushadhi Kendras.

Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), in last 10 years, sale of medicines worth Rs. 6100 crores have been done through Kendras, which has led to estimated savings of Rs. 30,000 Crores for the citizens as compared to the branded medicines.

Under the PMBJP, a medicine is priced on the principle of a maximum of 50% of the average price of the top three branded medicines. The price of Jan Aushadhi Medicines, surgical devices and nutraceutical products are cheaper at least by 50% and in some cases, by 80% to 90% of the market price of branded medicines available in the market. PMBI has already been progressing at very fact pace towards achieving the target of 25000 Jan Aushadhi Kendras in India.

TIOL CORP SEARCH

TIOL GROUP WEBSITES